EichorEICHOR
Condition: Oral Stage Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Oral Stage

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity
Phase 2 · 3 location(s) · ERX Pharmaceuticals · NCT07570758New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia
Phase 2 · 1 location(s) · Beth Israel Deaconess Medical Center · NCT06944145Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
Phase 3 · 27 location(s) · Amgen · NCT04528082Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients
NA · 1 location(s) · Mucosa Innovations, S.L. · NCT05635929Upfront Surgery Vs Induction Chemotherapy Followed By Surgery In Oral Cancers:
Phase 3 · 7 location(s) · All India Institute of Medical Sciences, Jodhpur · NCT06737822Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With H
Phase 1/Phase 2 · 12 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05660980A Study of Oral Tetrahydrouridine-Decitabine in Relapsed or Refractory Myelodysplastic Syndromes (MDS)
Phase 1 · 1 location(s) · Treebough Therapies · NCT07006025GIST Oral Paclitaxel(Liporaxel)
Phase 2 · 1 location(s) · Asan Medical Center · NCT06326346A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Phase 2 · 23 location(s) · Verastem, Inc. · NCT07644559Bone Substitutes and NIPSA in Intrabony Periodontal Defects: A Randomized Controlled Trial
NA · 2 location(s) · University of Belgrade · NCT07671963Mandibular Reconstruction Preplanning (ViPMR)
NA · 1 location(s) · University of British Columbia · NCT05429099Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Ag
Phase 1 · 27 location(s) · AbbVie · NCT06896916A Phase I/II Clinical Study of WJ22096 Tablets in Patients With Advanced Tumors
Phase 1/Phase 2 · 1 location(s) · Nanjing Jingao biomidical technology Co. Ltd. · NCT07253116Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis
EARLY_Phase 1 · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT05705414Orofacial Functions and Masticatory Function in Children With Different Types of Deterioration in Oral Health
NA · 1 location(s) · University Hospital, Clermont-Ferrand · NCT05821140A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · 81 location(s) · Merck Sharp & Dohme LLC · NCT07044297Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective
NA · 28 location(s) · Second Affiliated Hospital, Zhejiang University, School of M · NCT07402525A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients
Phase 3 · 2 location(s) · Shanghai Jiatan Pharmatech Co., Ltd · NCT05824871Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study
Phase 4 · 1 location(s) · The Cleveland Clinic · NCT04191681A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed
Phase 1/Phase 2 · 1 location(s) · Alzamend Neuro, Inc. · NCT07540338Safety, Tolerability, and Pharmacokinetics of HL-003 in Healthy Subjects
Phase 1 · 1 location(s) · Shanghai Kechow Pharma, Inc. · NCT06867393A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Admini
Phase 1/Phase 2 · 1 location(s) · Atlas Molecular Pharma · NCT07024316Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT
Phase 2 · 1 location(s) · Nabil Adra · NCT04804007A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients With Head and Neck Cance
Phase 3 · 11 location(s) · OncoZenge AB · NCT07672236A First-in-Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of Debio
Phase 1 · 1 location(s) · Debiopharm International SA · NCT07035769Pembrolizumab in Treating Participants With Leukoplakia
Phase 2 · 3 location(s) · Jonsson Comprehensive Cancer Center · NCT03603223Validation of the O-bridge Protocol: a Prospective, Multicenter Trial
Phase N/A · 5 location(s) · AZ Sint-Jan AV · NCT04007783Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA
Phase 1/Phase 2 · 1 location(s) · Milton S. Hershey Medical Center · NCT06600698Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA
Phase 2 · 1 location(s) · Henry Ford Health System · NCT06948552EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid Tumors
Phase 1 · 11 location(s) · Epics Therapeutics · NCT07163325
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.